Literature DB >> 6341645

Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.

J Mehta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6341645

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Antiplatelet effects of oral diltiazem, propranolol, and their combination.

Authors:  M E Ring; J J Corrigan; P E Fenster
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

2.  Hyperreactivity of platelets to serotonin (5-hydroxytryptamine) in patients with cardiovascular diseases. Influence of ketanserin, a serotonin S2-receptor antagonist.

Authors:  J De Crée; V Roels; H Verhaegen
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  The influence of fenflumizole on platelet aggregation in patients with unstable angina pectoris.

Authors:  A M Grauholt; P Grande; J Wadt
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Protective effects of andrographis paniculata nees on post-infarction myocardium in experimental dogs.

Authors:  H Y Zhao; W Y Fang
Journal:  J Tongji Med Univ       Date:  1990
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.